XML 36 R23.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Percentage of Net Revenue and Total Accounts Receivable (Detail) | 3 Months Ended | 6 Months Ended | 12 Months Ended
--- | --- | --- | ---
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | Mar. 31, 2017
Sales Revenue, Net | Governmental - Medicare/Medi-Cal |  |  |  |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |  |  |  |
Concentration Risk, Percentage | 73.00% |  | 21.90% |  | 72.50% |  | 22.60% |
Sales Revenue, Net | L.A Care |  |  |  |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |  |  |  |
Concentration Risk, Percentage |  | [1] | 0.00% | [1] |  | [1] | 11.90% |
Sales Revenue, Net | Allied Physicians [Member] |  |  |  |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |  |  |  |
Concentration Risk, Percentage |  | [1] | 0.00% | [1] |  | [1] | 11.30% |
Accounts Receivable | Governmental - Medicare/Medi-Cal |  |  |  |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |  |  |  |
Concentration Risk, Percentage |  |  |  |  | 24.30% |  |  | 20.50%
Accounts Receivable | Allied Physicians [Member] |  |  |  |  |  |  |  |
Accounts Receivable And Net Revenue [Line Items] |  |  |  |  |  |  |  |
Concentration Risk, Percentage |  |  |  |  | 12.50% |  |  | 12.80%
[1] | Represents less than 10%

X
- References No definition available. + Details
Name: | ameh_AccountsReceivableAndNetRevenueLineItems
Namespace Prefix: | ameh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6351-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13531-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6404-108592 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13537-108611 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=ameh_MedicareAndMedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=ameh_LCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=ameh_AlliedPhysiciansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |